Recent Finacing
Recent Raise
Synbody Biotechnology operates a drug‑discovery platform that uses unstructured synthetic peptides to generate synbodies—synthetic antibodies—to discover ligands for therapies across oncology, cardiovascular, CNS, diabetes, and infectious diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investor